For most people with asthma, final expense underwriting barely notices. FMO grids show it isn’t asked on several carriers’ applications — Mutual of Omaha, Foresters, Americo, and American Amicable among them. Where it is rated, it’s usually a day-one tier: Transamerica puts mild asthma at Preferred and chronic asthma at Standard; Royal Neighbors places asthma at Standard; United Home Life puts mild asthma with no hospitalization in two years at Premier; and FMO grids show Accendo at Standard.
The same inhaler can be rated two ways — the diagnosis next to it decides which. American Amicable’s Senior Choice drug guide lists albuterol, Advair, Symbicort, and Ventolin at its Immediate benefit when prescribed for asthma, with no time window; the same inhalers prescribed for COPD carry a two-year return-of-premium and three-year graded ladder. Aetna’s drug list also rates inhalers by condition. So know what your record says: if a doctor has charted COPD or emphysema, the COPD rules apply instead.
What carriers screen for is severe asthma: hospitalizations or ER visits, daily maintenance steroids, and tobacco. American Amicable’s term guides decline asthma with an ER visit or hospitalization in the past 12 months, maintenance steroid use, or smoking; Foresters’ non-medical term and Mutual of Omaha’s Express term decline severe asthma too. Final expense is usually more forgiving — and guaranteed-issue whole life asks no health questions at all: Mutual of Omaha’s runs to age 85, Corebridge’s and Americo’s to 80, with a graded period for natural-cause death in the first two years (three at Americo) and full accidental coverage from day one.